Longevity Treatment Guides

Choose a hospital or blood-bank apheresis program with an ASFA indication and emergency backup. A cash-pay longevity spa is not a TPE center.

TPE, plasmapheresis, and plasma donation overlap in language. Donation is not treatment. Medical TPE is a hospital procedure with infection, clotting, and access risks.

EBOO is not an established equivalent to medical TPE. Evidence is limited. TPE treats selected diseases in hospitals. Both involve access, clotting, and infection risk.

TPE replacement fluid is indication-specific. TTP needs donor plasma; many other exchanges use albumin. Wrong fluid can cause bleeding or transfusion reactions.

TPE for TTP and hyperviscosity is hospital specialty emergency care, not a wellness visit. Infection, clotting, hypocalcemia, and access complications apply.

TPE for selected neurologic autoimmune diseases is neurology-directed specialty care. ASFA and AAN describe contexts such as some MG and GBS. Not a wellness visit.

ASFA Categories I–IV rate medical TPE indications. Wellness longevity is not an ASFA indication. TPE is a specialty procedure with infection, clotting, and access risks.

Plasma exchange for longevity rests on animal work and early human studies. It is costly, speculative, and not proven preventive care. Infection and clotting remain risks.

Centrifugal and membrane TPE both remove plasma. Efficiency, access, and citrate load differ. Neither method is a proven aging treatment. Hospital specialty care.

An extracorporeal medical procedure that removes a large volume of plasma and replaces it with albumin, donor plasma, or another prescribed fluid. TPE has disease-specific guideline roles but is not an established anti-aging or detox treatment.